[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345226-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-345226-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","impact-of-the-2013-who-guidelines-for-screening-and-treatment-of-cervical-precancerous-lesions-on-womens-screening-uptake-by-hiv-status-in-eastern-and-southern-africa","Impact of the 2013 WHO guidelines for screening and treatment of cervical precancerous lesions - on women’s screening uptake, by HIV-status, in Eastern and Southern Africa","","The 2013 WHO guidelines advised cervical pre-cancer screening for women aged 30–49 and for women living with HIV starting at age 25, yet the effect of these recommendations on screening uptake remained unclear. A regression discontinuity design used population survey data from six Eastern and Southern African countries to compare screening rates before and after guideline adoption, stratified by HIV status and age. Results found no overall guideline impact, though adolescents and young women living with HIV reported lower screening frequency.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impact-of-the-2013-who-guidelines-for-screening-and-treatment-of-cervical-precancerous-lesions-on-womens-screening-uptake-by-hiv-status-in-eastern-and-southern-africa/345226/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impact-of-the-2013-who-guidelines-for-screening-and-treatment-of-cervical-precancerous-lesions-on-womens-screening-uptake-by-hiv-status-in-eastern-and-southern-africa/345226.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What screening ages did the 2013 WHO guidelines recommend for cervical pre-cancer?","Question",{"text":63,"@type":64},"They recommended screening for women aged 30–49 and for women living with HIV starting at age 25.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which study method and countries were used to evaluate the guidelines’ impact?",{"text":68,"@type":64},"The analysis used a regression discontinuity design with population-based data from Ethiopia, Malawi, Rwanda, Tanzania, Zambia, and Zimbabwe.",{"name":70,"@type":61,"acceptedAnswer":71},"Did the 2013 WHO guidelines change overall cervical pre-cancer screening uptake?",{"text":72,"@type":64},"No evidence was found that the guidelines impacted women’s overall screening uptake.",{"name":74,"@type":61,"acceptedAnswer":75},"What subgroup showed lower screening rates and what recommendation followed?",{"text":76,"@type":64},"Adolescent girls and young women living with HIV (ages 15–24) reported screening less often, leading to a recommendation to lower the screening age for women living with HIV to 15.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},345226,1790137421,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":117,"preview_page_count":33,"preview_urls":149},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Chipanta etal. Reproductive Health (2026) 23:86 Reproductive Health  \n[https://doi.org/10.1186/s12978-026-02274-4](https://doi.org/10.1186/s12978-026-02274-4)  \nRESEARCH Open Access  \nImpact of the 2013 WHO guidelines for screening and treatment of cervical precancerous lesions on women’s screening uptake, by HIV-status, in Eastern and Southern Africa: a regression discontinuity design analysis  \nDavid Chipanta1*, Connie Osborne3, Julia Bohlius4, Ani Shakarishvili2, Silas Amo-Agyei5, Alinane Linda Nyondo-Mipando6, Janne Anton Markus Estill7† and Olivia Keiser7†  \nAbstract  \nBackground The 2013 World Health Organization (WHO) guidelines for cervical pre-cancer screening recommended screening women aged 30–49 and women living with HIV (WLHIV) starting at age 25. However, the impact of the guidelines and the age to start screening on screening uptake has not been studied.  \nMethods We used a regression discontinuity design analysis of population-based data to assess the impact of the guidelines on the screening rates for women according to HIV status and age group in Ethiopia, Malawi, Rwanda, Tanzania, Zambia, and Zimbabwe. Although the PHIA surveys were conducted after 2014, when countries adopted the guidelines, the women were asked to report whether they had been screened for cervical pre-cancer at any point between 2008 and 2018. From the women’s screening reports, we identified reports of being screened from 2008 to 2014 and after 2014 to 2018. These reports were random and unique. They enabled us to compare the screening rates from the period 2008 to 2014 and after 2014 to 2018 ‒ pre and post the intervention ‒ by HIV status, and before and after the age of 25 years. We used a data-driven optimal bandwidth selection procedure to estimate the guidelines’average treatment effect with local polynomial regression discontinuity and robust bias-corrected confidence intervals.  \n†Janne Anton Markus Estill and Olivia Keiser contributed equally to this work.  \n*Correspondence: David Chipanta[chipantad@unaids.org](chipantad@unaids.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nResults We included 73,179 women: 6680 (9 . 1%) living with HIV, 4328 (5 . 9%) with unknown HIV status, and 62,171 (85 . 0) with a negative HIV status. Adolescent girls and young women living with HIV (AGYWLHIV) aged 15–24 reported screening less often (102 (6 . 1%)) than their peers with unknown (66 (7 . 2%)) (P \u003C 0. 001), or or older women. Conclusions We found no evidence the 2013 WHO guidelines impacted women’s cervical pre-cancer screening uptake. However, AGYWLHIV reported screening less often. Policymakers should lower the age to screen WLHIV from 25 to 15 to screen more AGYWLHIV. Studies are required to examine the impact of the guidelines on cervical precancer screening in more countries.  \nPlain","cbCailVWFSNFsQ3N","https://ap.wps.com/l/cbCailVWFSNFsQ3N","pdf",1813173,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Plain English summary\n## Key recommendation","[{\"question\":\"What screening ages did the 2013 WHO guidelines recommend for cervical pre-cancer?\",\"answer\":\"They recommended screening for women aged 30–49 and for women living with HIV starting at age 25.\"},{\"question\":\"Which study method and countries were used to evaluate the guidelines’ impact?\",\"answer\":\"The analysis used a regression discontinuity design with population-based data from Ethiopia, Malawi, Rwanda, Tanzania, Zambia, and Zimbabwe.\"},{\"question\":\"Did the 2013 WHO guidelines change overall cervical pre-cancer screening uptake?\",\"answer\":\"No evidence was found that the guidelines impacted women’s overall screening uptake.\"},{\"question\":\"What subgroup showed lower screening rates and what recommendation followed?\",\"answer\":\"Adolescent girls and young women living with HIV (ages 15–24) reported screening less often, leading to a recommendation to lower the screening age for women living with HIV to 15.\"}]","Impact of the 2013 WHO guidelines for screening and treatment of cervical precancerous lesions - on women’s screening uptake, by HIV-status, in Eastern and Southern Africa | PDF",1790056885,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/740a594f39273ef7172add1b99fbd324.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7de76d06caef912482e86894c98d5b5.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71fc9cc66831c068e44996c627cefc0d.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e533b9314c2374df16d2076ee2f34fa.webp",980,1306]